PT1053329E - Proteína psaa lipidada recombinante, métodos de preparação e utilização - Google Patents
Proteína psaa lipidada recombinante, métodos de preparação e utilização Download PDFInfo
- Publication number
- PT1053329E PT1053329E PT99903011T PT99903011T PT1053329E PT 1053329 E PT1053329 E PT 1053329E PT 99903011 T PT99903011 T PT 99903011T PT 99903011 T PT99903011 T PT 99903011T PT 1053329 E PT1053329 E PT 1053329E
- Authority
- PT
- Portugal
- Prior art keywords
- proteins
- lipidated psaa
- methods
- preparation
- lipidated
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 101710099976 Photosystem I P700 chlorophyll a apoprotein A1 Proteins 0.000 abstract 5
- 229960005486 vaccine Drugs 0.000 abstract 2
- 101100130893 Alkalihalobacillus halodurans (strain ATCC BAA-125 / DSM 18197 / FERM 7344 / JCM 9153 / C-125) mntA gene Proteins 0.000 abstract 1
- 241000589969 Borreliella burgdorferi Species 0.000 abstract 1
- 101100084597 Dictyostelium discoideum pspA gene Proteins 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000029226 lipidation Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 101150045801 ospA gene Proteins 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 101150043479 psaA gene Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1778298A | 1998-02-03 | 1998-02-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1053329E true PT1053329E (pt) | 2010-01-04 |
Family
ID=21784518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99903011T PT1053329E (pt) | 1998-02-03 | 1999-01-14 | Proteína psaa lipidada recombinante, métodos de preparação e utilização |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7635486B1 (pt) |
| EP (1) | EP1053329B1 (pt) |
| JP (1) | JP4290875B2 (pt) |
| AT (1) | ATE445015T1 (pt) |
| AU (1) | AU2313199A (pt) |
| BR (1) | BR9909097A (pt) |
| CA (1) | CA2319404C (pt) |
| DE (1) | DE69941505D1 (pt) |
| DK (1) | DK1053329T3 (pt) |
| ES (1) | ES2334185T3 (pt) |
| NZ (1) | NZ525674A (pt) |
| PT (1) | PT1053329E (pt) |
| WO (1) | WO1999040200A1 (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6903184B1 (en) | 1998-03-02 | 2005-06-07 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Multiple antigenic peptides immunogenic against Streptococcus pneumonia |
| PT1790660E (pt) * | 2000-02-28 | 2012-09-17 | Novartis Vaccines & Diagnostic | Expressão heteróloga de proteínas de neisseria |
| AU7193501A (en) * | 2000-07-10 | 2002-01-21 | Us Health | Multiple antigenic peptides immunogenic against streptococcus pneumoniae |
| MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
| MXPA05011110A (es) * | 2003-04-16 | 2006-01-24 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de un padecimiento originado por meningococos. |
| AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
| PL3246044T5 (pl) | 2010-08-23 | 2024-06-17 | Wyeth Llc | Stabilne preparaty antygenów rLP2086 Neisseria meningitidis |
| PE20140173A1 (es) | 2010-09-10 | 2014-02-20 | Wyeth Llc | Variantes no lipidadas de antigenos orf2086 de neisseria meningitidis |
| SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
| EP4043029A1 (en) | 2012-03-09 | 2022-08-17 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| US9802987B2 (en) | 2013-03-08 | 2017-10-31 | Pfizer Inc. | Immunogenic fusion polypeptides |
| EP3041502A2 (en) | 2013-09-08 | 2016-07-13 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| CN103773779B (zh) * | 2013-12-31 | 2017-02-15 | 李越希 | 化学合成肺炎链球菌表面粘附素a的基因片段及表达、应用 |
| US10888611B2 (en) | 2015-02-19 | 2021-01-12 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| CN108884134A (zh) * | 2015-12-10 | 2018-11-23 | 加拿大全国研究委员会 | 脂化肺炎链球菌抗原组合物、制备方法和用途 |
| JP7010961B2 (ja) | 2017-01-31 | 2022-02-10 | ファイザー・インク | 髄膜炎菌組成物およびその方法 |
| KR102871663B1 (ko) | 2019-09-27 | 2025-10-16 | 화이자 인코포레이티드 | 네이세리아 메닌기티디스 조성물 및 그의 방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993010238A1 (en) | 1991-11-14 | 1993-05-27 | The Government Of The United States Of America As Represented By The Department Of Health And Human Services | Pneumococcal fimbrial protein a vaccines |
| ES2271954T3 (es) | 1995-06-07 | 2007-04-16 | Sanofi Pasteur Inc. | Expresion de lipoproteinas. |
| US6924112B1 (en) * | 1997-12-04 | 2005-08-02 | Biomethodes S.A.R.L. | Cloning method by multiple-digestion, vectors for implementing same and applications |
| NO983911D0 (no) * | 1998-08-26 | 1998-08-26 | Norsk Hydro As | Alginatkapsler til bruk ved behandling av hjernesvulst |
-
1999
- 1999-01-14 AU AU23131/99A patent/AU2313199A/en not_active Abandoned
- 1999-01-14 PT PT99903011T patent/PT1053329E/pt unknown
- 1999-01-14 NZ NZ525674A patent/NZ525674A/en not_active IP Right Cessation
- 1999-01-14 JP JP2000530614A patent/JP4290875B2/ja not_active Expired - Fee Related
- 1999-01-14 ES ES99903011T patent/ES2334185T3/es not_active Expired - Lifetime
- 1999-01-14 AT AT99903011T patent/ATE445015T1/de active
- 1999-01-14 EP EP99903011A patent/EP1053329B1/en not_active Expired - Lifetime
- 1999-01-14 CA CA2319404A patent/CA2319404C/en not_active Expired - Fee Related
- 1999-01-14 DE DE69941505T patent/DE69941505D1/de not_active Expired - Lifetime
- 1999-01-14 US US09/600,057 patent/US7635486B1/en not_active Expired - Fee Related
- 1999-01-14 DK DK99903011.7T patent/DK1053329T3/da active
- 1999-01-14 WO PCT/US1999/000379 patent/WO1999040200A1/en not_active Ceased
- 1999-01-14 BR BR9909097-0A patent/BR9909097A/pt not_active Application Discontinuation
-
2009
- 2009-11-16 US US12/619,357 patent/US7960535B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7635486B1 (en) | 2009-12-22 |
| JP4290875B2 (ja) | 2009-07-08 |
| DE69941505D1 (de) | 2009-11-19 |
| ATE445015T1 (de) | 2009-10-15 |
| EP1053329A1 (en) | 2000-11-22 |
| US20100260802A1 (en) | 2010-10-14 |
| NZ525674A (en) | 2005-01-28 |
| EP1053329B1 (en) | 2009-10-07 |
| DK1053329T3 (da) | 2010-01-25 |
| CA2319404A1 (en) | 1999-08-12 |
| ES2334185T3 (es) | 2010-03-05 |
| WO1999040200A1 (en) | 1999-08-12 |
| JP2002505083A (ja) | 2002-02-19 |
| CA2319404C (en) | 2014-01-07 |
| US7960535B2 (en) | 2011-06-14 |
| BR9909097A (pt) | 2000-12-05 |
| AU2313199A (en) | 1999-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1053329E (pt) | Proteína psaa lipidada recombinante, métodos de preparação e utilização | |
| PL338478A1 (en) | Immunological response in respect to hpv antigens induced by compositions comprising a hpv antigen and a shock protein or expression vector capable to express such protein | |
| EP1801219A3 (en) | Neisserial antigenic peptides | |
| CA2168459A1 (en) | Fusion proteins containing the c-terminal of tetanus toxin linked to a heterologous protein | |
| PL336295A1 (en) | Modified tnfalpha molecule, dna encoding such molecule and vaccine comprising such tnfalpha molecule and such dna | |
| FR2686896B1 (fr) | Mutant attenue de listeria monocytogenes; souche recombinante de listeria monocytogenes, utilisation comme vecteurs heterologues d'antigenes vaccinal et utilisation comme vaccin ou composition diagnostique. | |
| MXPA01008966A (es) | Vacunas contra el virus sincicial respiratorio a base de acido nucleico. | |
| NZ333999A (en) | GnRH-leukotoxin chimeric proteins for use in vaccines | |
| IL70776A (en) | Recombinant dna molecule encoding at least one polypeptide displaying the immunogenicity of at least one merozoite antigen or asexual blood stage antigen of p.falciparum,vectors comprising the dna molecule,host cells transformed thereby,immunogenic polypeptides produced by host cells and compositions containing the polypeptides | |
| WO2003065973A8 (en) | Multivalent streptococcal vaccine compositions and methods for use | |
| WO2003088995A3 (en) | Mucin fusion polypeptide vaccines, compositions and methods of use thereof | |
| CA2171611A1 (en) | Analog of haemophilus hin47 with reduced protease activity | |
| AU4119996A (en) | Carrier protein having an adjuvant effect, immunogenic complex containing same, preparation method therefor, nucleotide sequence and vaccine | |
| NZ507983A (en) | A polypeptide comprising the amino acid of an n- terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof | |
| CA2072095A1 (en) | Outer membrane protein p1 and peptides of haemophilus influenzae type b | |
| MXPA03010527A (es) | Composicion de vacuna. | |
| WO2002051237A3 (en) | Helicobacter proteins, nucleic acids and uses thereof | |
| EP0378929A3 (en) | Membrane proteins and peptides of haemophilus influenzae type b | |
| AU6761301A (en) | Adjuvant composition comprising fha protein or fragment of fha protein in free form | |
| AU2001239262A1 (en) | Haemophilus influenza outer membrane protein and use thereof in vaccination | |
| CA2182315A1 (en) | Expression of heterologous proteins in attenuated bacteria using the htra-promoters | |
| AU2001281943A1 (en) | The t-cell protein (tzon7), peptides and antibodies derived therefrom and uses thereof | |
| WO2001077329A3 (en) | Human twik molecules and uses thereof | |
| WO2004011496A3 (en) | Novel t-cell proteins, peptides and antibodies derived therefrom and uses thereof | |
| EP1535928A3 (en) | Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis, compositions containing same and methods of use thereof |